Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine pharmacokinetics during continuous venovenous hemofiltration and hemodiafiltration in critically ill patients
2010-023455-28Phase 2Terminated
- Sponsor
- Maija Kaukonen
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of dexmedetomidine in acute kidney failure (AKF) and critical illness, sponsored by Maija Kaukonen. Primary endpoints: Dexmedetomidine clearance during CVVH/CVVHDF, Volume of distribution and 3 more. Started Nov 2010; status: terminated.
02
Drugs
dexmedetomidine
03
Conditions
acute kidney failure (AKF)critical illness
Beyond the preview
Go deeper on 2010-023455-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-023455-28.